ELI LILLY & Co
NYSE · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Eli Lilly & Co is a pharmaceutical company that discovers, develops, and sells prescription medicines, including treatments for diabetes, obesity, oncology, immunology, and neuroscience conditions.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Jonsson PatrikEVP & President, LLY Int'l | Sell | $7.64M | 6,500at $1175.10 | Aug 17, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Dan NewhouseWA04 | House | Sell | $1,001 - $15,000 | Jul 10, 2026 |
| Michael RulliOH06 | House | Sell | $1,001 - $15,000 | Jul 1, 2026 |
| Gilbert CisnerosCA31 | House | Buy | $50,001 - $100,000 | Jun 10, 2026 |
| Alan ArmstrongArmstrong, Alan (Senator) | Senate | Sell | $1,001 - $15,000 | Mar 27, 2026 |
| Michael RulliOH06 | House | Buy | $1,001 - $15,000 | Jan 2, 2026 |
| Michael RulliOH06 | House | Sell | $1,001 - $15,000 | Dec 2, 2025 |
| John BoozmanBoozman, John (Senator) | Senate | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Thomas H TubervilleTuberville, Tommy (Senator) | Senate | Sell | $15,001 - $50,000 | Apr 15, 2025 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable LLY activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.